Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:ATM NYSEARCA:CAPD NASDAQ:PRE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATMRio2C$0.68+1.5%C$0.68C$0.57▼C$0.86C$57.62MN/A114,654 shs15,000 shsCAPDiPath Shiller CAPE ETN$19.37+0.2%$19.37$17.73▼$23.10$335.88MN/A120,878 shs263,800 shsPREPrenetics Global$16.16+1.8%$18.73$5.08▼$23.63$271.94M0.15169,599 shs224,889 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATMRio20.00%0.00%0.00%0.00%0.00%CAPDiPath Shiller CAPE ETN0.00%0.00%0.00%0.00%0.00%PREPrenetics Global+1.83%-5.05%-7.50%-16.01%+210.83%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATMRio2C$0.68+1.5%C$0.68C$0.57▼C$0.86C$57.62MN/A114,654 shs15,000 shsCAPDiPath Shiller CAPE ETN$19.37+0.2%$19.37$17.73▼$23.10$335.88MN/A120,878 shs263,800 shsPREPrenetics Global$16.16+1.8%$18.73$5.08▼$23.63$271.94M0.15169,599 shs224,889 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATMRio20.00%0.00%0.00%0.00%0.00%CAPDiPath Shiller CAPE ETN0.00%0.00%0.00%0.00%0.00%PREPrenetics Global+1.83%-5.05%-7.50%-16.01%+210.83%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATMRio2 0.00N/AN/AN/ACAPDiPath Shiller CAPE ETN 0.00N/AN/AN/APREPrenetics Global 2.50Moderate Buy$32.33100.08% UpsideCurrent Analyst Ratings BreakdownLatest ATM, PRE, CAPD, and SVML Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/21/2026PREPrenetics Global Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)3/16/2026PREPrenetics Global Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$29.002/11/2026PREPrenetics Global Roth MkmSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$36.00(Data available from 5/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATMRio2N/AN/AN/AN/AN/AN/ACAPDiPath Shiller CAPE ETNN/AN/AN/AN/AN/AN/APREPrenetics Global$92.39M2.94N/AN/A$9.29 per share1.74Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATMRio2N/AN/AN/AN/AN/AN/AN/AN/AN/ACAPDiPath Shiller CAPE ETNN/AN/AN/AN/AN/AN/AN/AN/AN/APREPrenetics Global-$37.71M-$4.02N/A26.06N/A-61.33%-19.61%-15.33%5/14/2026 (Estimated)Latest ATM, PRE, CAPD, and SVML EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026PREPrenetics Global-$0.66N/AN/AN/A$37.90 millionN/A2/18/2026Q4 2025PREPrenetics Global-$0.49-$0.27+$0.22-$1.75$36.15 million$36.60 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthATMRio2N/AN/AN/AN/AN/ACAPDiPath Shiller CAPE ETNN/A0.00%N/AN/AN/APREPrenetics Global$2.8017.33%N/AN/A N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioATMRio2N/AN/AN/ACAPDiPath Shiller CAPE ETNN/AN/AN/APREPrenetics GlobalN/A2.972.72Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATMRio2N/ACAPDiPath Shiller CAPE ETNN/APREPrenetics Global25.01%Insider OwnershipCompanyInsider OwnershipATMRio2N/ACAPDiPath Shiller CAPE ETNN/APREPrenetics Global7.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATMRio2N/A84.74 millionN/ANot OptionableCAPDiPath Shiller CAPE ETNN/A17.34 millionN/ANot OptionablePREPrenetics Global116.83 million15.52 millionNot OptionableATM, PRE, CAPD, and SVML HeadlinesRecent News About These CompaniesPrenetics Global Limited to Announce Q1 2026 Financial Results on May 14, 2026May 8 at 8:50 AM | quiverquant.comQPrenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference CallMay 8 at 8:30 AM | globenewswire.comPrenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year PartnershipMay 7 at 1:56 PM | markets.businessinsider.comPrenetics' IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year PartnershipMay 7 at 8:30 AM | globenewswire.comPrenetics Global (PRE) Projected to Post Earnings on ThursdayMay 7 at 4:53 AM | marketbeat.comPrenetics to Exit Bitcoin Holdings and Reinvest Up to $40 Million in Core IM8 Health BusinessMay 6, 2026 | theglobeandmail.comPrenetics Global (NASDAQ:PRE) Trading Up 1.9% - Should You Buy?May 2, 2026 | marketbeat.comPrenetics Global Ltd.April 23, 2026 | barrons.comPrenetics Global Ltd. WtApril 17, 2026 | barrons.comPrenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year OneApril 14, 2026 | markets.businessinsider.comPrenetics Global Limited Warrant (PRENW) Real TimeApril 11, 2026 | nasdaq.comWhat is Zacks Research's Estimate for PRE Q1 Earnings?April 10, 2026 | marketbeat.comInitiating Coverage of Rapid-Growing PREApril 8, 2026 | finance.yahoo.comPrenetics Brings Giannis Antetokounmpo Onboard as IM8 Global Partner and ShareholderApril 8, 2026 | theglobeandmail.comPrenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year PartnershipApril 2, 2026 | markets.businessinsider.com7 fastest growing Asian stocks to buyApril 2, 2026 | msn.comPrenetics Global (PRE) Partners with Superpower on Diagnostics and SupplementsApril 1, 2026 | insidermonkey.comIM8 Partners with Superpower to Offer Subscribers Exclusive Blood Testing Membership at 75% DiscountMarch 24, 2026 | quiverquant.comQPrenetics' IM8 Partners with Superpower to Personalize the Future of SupplementationMarch 24, 2026 | globenewswire.comPrenetics to Participate in the 38th Annual ROTH ConferenceMarch 18, 2026 | markets.businessinsider.comLake Street initiates coverage of Prenetics Global (PRE) with buy recommendationMarch 17, 2026 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesAI, Satellites and Staples: Insiders Are Buying and Selling 3 Big NamesBy Leo Miller | April 13, 2026A Quiet Outperformer With a Catastrophe CaveatBy Peter Frank | April 14, 2026Roblox Stock Slides to New Low as Safety Changes Weigh on OutlookBy Jennifer Ryan Woods | May 3, 20261 Stock Is Powering the AI Boom and the Next Farm SupercycleBy Jeffrey Neal Johnson | April 22, 2026Inflation Shock Ahead? Get Ready for ImpactBy Thomas Hughes | April 17, 2026ATM, PRE, CAPD, and SVML Company DescriptionsRio2 CVE:ATMC$0.68 +0.01 (+1.49%) As of 07/26/2018Atacama Pacific Gold Corporation, an exploration stage company, engages in the acquisition, exploration, and development of gold properties in Chile. The company principally holds a 100% interest in the Cerro Maricunga gold project located in Region III northeast of the city of Copiapo. Atacama Pacific Gold Corporation was incorporated in 2008 and is headquartered in Toronto, Canada.iPath Shiller CAPE ETN NYSEARCA:CAPD$19.37 +0.04 (+0.21%) As of 10/11/2022Prenetics Global NASDAQ:PRE$16.16 +0.29 (+1.83%) Closing price 05/8/2026 04:00 PM EasternExtended Trading$15.74 -0.42 (-2.61%) As of 05/8/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/04 - 05/08 SoundHound’s Bottom Is In—Inflection and 50% Upside Ahead? Rocket Lab Posts Record Q1 Revenue, Raises Q2 Guidance 3 Under-The-Radar Small Caps Making New All-Time Highs Flutter Sees Post-Earnings Boost as FanDuel Shows Signs of Recovery Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus AppLovin Pops After Earnings With Growth Catalysts in Sight Dutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality Check Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
